Karine Breckpot spends much of her time researching Immunology, Cytotoxic T cell, Antigen, Immune system and Dendritic cell. Her studies in Immunology integrate themes in fields like Cancer cell and Clinical trial. Karine Breckpot has included themes like Molecular biology and Cancer immunotherapy in her Antigen study.
Karine Breckpot combines subjects such as Cancer research, Genetic enhancement, Tumor antigen and In vivo with her study of Cancer immunotherapy. All of her Immune system and Immunotherapy and Toll-like receptor investigations are sub-components of the entire Immune system study. T cell and Conserved sequence is closely connected to Cell biology in her research, which is encompassed under the umbrella topic of Dendritic cell.
Karine Breckpot focuses on Cancer research, Immunology, Immune system, Immunotherapy and Dendritic cell. Her Cancer research study combines topics from a wide range of disciplines, such as Tumor microenvironment, Cancer, Cancer immunotherapy, PD-L1 and In vivo. Her studies examine the connections between Cancer immunotherapy and genetics, as well as such issues in Viral vector, with regards to Genetic enhancement.
Her research integrates issues of Ex vivo and Cell therapy in her study of Immunology. Her Immune system research is multidisciplinary, incorporating perspectives in Cancer cell, Myeloid-derived Suppressor Cell and Antigen. As a part of the same scientific study, Karine Breckpot usually deals with the Dendritic cell, concentrating on Cell biology and frequently concerns with CD40 and Cell.
Her primary areas of investigation include Cancer research, Immune system, Cancer, Immunotherapy and PD-L1. Her studies deal with areas such as Immune checkpoint, Tumor microenvironment, T cell, Immunogenic cell death and Single-domain antibody as well as Cancer research. The study incorporates disciplines such as Peripheral tolerance, Dendritic cell, Immune tolerance and Antigen in addition to Tumor microenvironment.
Karine Breckpot works mostly in the field of Immune system, limiting it down to topics relating to Monoclonal antibody and, in certain cases, Molecular biology and Breast cancer. The Cancer cell research Karine Breckpot does as part of her general Cancer study is frequently linked to other disciplines of science, such as Neuropilin 1, therefore creating a link between diverse domains of science. In her study, which falls under the umbrella issue of Immunotherapy, CD8 and Viral vector is strongly linked to Cytotoxic T cell.
Karine Breckpot mainly focuses on Cancer research, Immunotherapy, Immune system, T cell and Dendritic cell. The concepts of her Cancer research study are interwoven with issues in Tumor microenvironment, Metastasis, Monoclonal antibody and Immune checkpoint. Karine Breckpot works mostly in the field of Immunotherapy, limiting it down to topics relating to Cancer cell and, in certain cases, Myelopoiesis, as a part of the same area of interest.
Her work carried out in the field of Immune system brings together such families of science as Epigenetics and DNA Methyltransferase Inhibitor. Her T cell study incorporates themes from Cell, Cytotoxic T cell and Cancer immunotherapy. Her Dendritic cell research is multidisciplinary, relying on both Immunogenic cell death, Plasma cell, CD8 and Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Consensus guidelines for the detection of immunogenic cell death
Oliver Kepp;Laura Senovilla;Ilio Vitale;Erika Vacchelli.
Lentiviral vectors in gene therapy: their current status and future potential.
David Escors;Karine Breckpot;Karine Breckpot.
Archivum Immunologiae Et Therapiae Experimentalis (2010)
Combinatorial Strategies for the Induction of Immunogenic Cell Death
Lucillia Bezu;Ligia C. Gomes-de-Silva;Heleen Dewitte;Karine Breckpot.
Frontiers in Immunology (2015)
Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death
Abhishek D. Garg;Lorenzo Galluzzi;Lionel Apetoh;Lionel Apetoh;Thais Baert.
Frontiers in Immunology (2015)
Nanobody-Based Targeting of the Macrophage Mannose Receptor for Effective In Vivo Imaging of Tumor-Associated Macrophages
Kiavash Movahedi;Steve Schoonooghe;Damya Laoui;Isabelle Houbracken.
Cancer Research (2012)
CD83 expression on dendritic cells and T cells: correlation with effective immune responses.
Cindy Aerts-Toegaert;Carlo Heirman;Sandra Tuyaerts;Jurgen Corthals.
European Journal of Immunology (2007)
Messenger RNA-electroporated dendritic cells presenting MAGE-A3 simultaneously in HLA class I and class II molecules.
Aude Bonehill;Carlo Heirman;Sandra Tuyaerts;Annelies Michiels.
Journal of Immunology (2004)
Current approaches in dendritic cell generation and future implications for cancer immunotherapy.
Sandra Tuyaerts;Joeri L. Aerts;Jurgen Corthals;Bart Neyns.
Cancer Immunology, Immunotherapy (2007)
Lentivirally transduced dendritic cells as a tool for cancer immunotherapy.
Karine Breckpot;Melissa Dullaers;Aude Bonehill;Sonja Van Meirvenne.
Journal of Gene Medicine (2003)
Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor Therapy
Sandra Van Lint;Cleo Goyvaerts;Sarah Maenhout;Lode Goethals.
Cancer Research (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: